Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report

The allogeneic therapeutic vaccine CSF-470 has demonstrated a significant benefit over medium-dose IFNα2b in the distant metastasis-free survival for stages IIB–IIC–III cutaneous melanoma patients in a randomized phase II/III clinical trial (CASVAC-0401, NCT01729663). At the end of the 2-year CSF-47...

Descripción completa

Detalles Bibliográficos
Autores principales: Aris, Mariana, Bravo, Alicia Inés, Pampena, María Betina, Blanco, Paula Alejandra, Carri, Ibel, Koile, Daniel, Yankilevich, Patricio, Levy, Estrella Mariel, Barrio, María Marcela, Mordoh, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944263/
https://www.ncbi.nlm.nih.gov/pubmed/29774030
http://dx.doi.org/10.3389/fimmu.2018.00955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944263/
https://www.ncbi.nlm.nih.gov/pubmed/29774030
http://dx.doi.org/10.3389/fimmu.2018.00955

Ejemplares similares